Hempacco Co., Inc. (HPCO)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -1.21 Million USD | -608.62% |
| 2022 | 239.04 Thousand USD | -28.93% |
| 2021 | 336.37 Thousand USD | 160.75% |
| 2020 | -553.71 Thousand USD | -10282.71% |
| 2019 | -5333.00 USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | -177.45 Thousand USD | -82.26% |
| 2023 Q1 | -97.36 Thousand USD | 75.89% |
| 2023 FY | -1.21 Million USD | -608.62% |
| 2023 Q4 | -503.02 Thousand USD | -14.85% |
| 2023 Q3 | -437.99 Thousand USD | -146.82% |
| 2022 Q4 | -403.75 Thousand USD | -6216.51% |
| 2022 Q3 | -6392.00 USD | -101.34% |
| 2022 Q2 | 477.02 Thousand USD | 177.08% |
| 2022 FY | 239.04 Thousand USD | -28.93% |
| 2022 Q1 | 172.16 Thousand USD | 339.77% |
| 2021 Q1 | 33.77 Thousand USD | 107.0% |
| 2021 FY | 336.37 Thousand USD | 160.75% |
| 2021 Q4 | 39.14 Thousand USD | -64.38% |
| 2021 Q3 | 109.89 Thousand USD | -28.44% |
| 2021 Q2 | 153.56 Thousand USD | 354.72% |
| 2020 FY | -553.71 Thousand USD | -10282.71% |
| 2020 Q4 | -482.73 Thousand USD | 0.0% |
| 2019 FY | -5333.00 USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | 73.06 Million USD | 101.664% |
| Theratechnologies Inc. | 62.12 Million USD | 101.957% |
| Safety Shot Inc | -74.45 Thousand USD | -1532.933% |
| Cosmos Health Inc. | 4.34 Million USD | 127.953% |
| Cronos Group Inc. | 6.99 Million USD | 117.392% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 100.276% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | -301.265% |
| Organogenesis Holdings Inc. | 309.79 Million USD | 100.392% |
| Universe Pharmaceuticals INC | 10.07 Million USD | 112.064% |
| ProPhase Labs, Inc. | 16.23 Million USD | 107.487% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | 125.623% |
| Dynavax Technologies Corporation | 182.11 Million USD | 100.668% |
| Radius Health, Inc. | 307.71 Million USD | 100.395% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | 319.476% |
| Alvotech | -69.42 Million USD | 98.249% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | 114.58% |
| Alpha Teknova, Inc. | 10.29 Million USD | 111.809% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | 100.282% |
| SCYNEXIS, Inc. | 124.51 Million USD | 100.976% |
| Harrow Health, Inc. | 90.55 Million USD | 101.343% |
| Biofrontera Inc. | 16.62 Million USD | 107.312% |
| DURECT Corporation | 6.83 Million USD | 117.799% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 100.232% |
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | 100.398% |
| OptiNose, Inc. | 62.35 Million USD | 101.95% |
| RedHill Biopharma Ltd. | 3.05 Million USD | 139.809% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | 104.087% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | 103.631% |
| SIGA Technologies, Inc. | 122.09 Million USD | 100.996% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | 102.905% |
| Shineco, Inc. | 882.16 Thousand USD | 237.823% |
| Phibro Animal Health Corporation | 312.48 Million USD | 100.389% |
| Procaps Group S.A. | 239.56 Million USD | 100.508% |
| TherapeuticsMD, Inc. | 1.3 Million USD | 193.382% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | -63.07% |
| Viatris Inc. | 6.43 Billion USD | 100.019% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | 114.58% |
| Rockwell Medical, Inc. | 8.7 Million USD | 113.969% |
| Incannex Healthcare Limited | 12 Thousand USD | 10231.942% |
| Aytu BioPharma, Inc. | 54.58 Million USD | 102.227% |
| Tilray Brands, Inc. | 223.35 Million USD | 100.544% |
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | 100.373% |
| PetIQ, Inc. | 252.74 Million USD | 100.481% |
| Silver Spike Investment Corp. | 8.1 Million USD | 115.005% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 100.066% |
| Journey Medical Corporation | 52.52 Million USD | 102.315% |
| Alimera Sciences, Inc. | 61.17 Million USD | 101.988% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | 129.009% |
| Assertio Holdings, Inc. | 125.04 Million USD | 100.972% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | -17751.02% |
| Embecta Corp. | 749.9 Million USD | 100.162% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 49.554% |
| Procaps Group, S.A. | 239.56 Million USD | 100.508% |
| PainReform Ltd. | -15 Thousand USD | -8005.553% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | 104.484% |
| Talphera, Inc. | -4.89 Million USD | 75.162% |
| Pacira BioSciences, Inc. | 490.3 Million USD | 100.248% |
| Alvotech | -69.42 Million USD | 98.249% |
| Lantheus Holdings, Inc. | 709.54 Million USD | 100.171% |
| Kamada Ltd. | 52.59 Million USD | 102.312% |
| Indivior PLC | 907 Million USD | 100.134% |
| Currenc Group, Inc. | 17.35 Million USD | 107.005% |
| Evoke Pharma, Inc. | 4.97 Million USD | 124.42% |
| Flora Growth Corp. | 17.73 Million USD | 106.854% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 49.554% |
| Evolus, Inc. | 140.52 Million USD | 100.865% |
| HUTCHMED (China) Limited | 453.55 Million USD | 100.268% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 100.353% |
| Akanda Corp. | 111.44 Thousand USD | 1190.932% |